Literature DB >> 25670037

Viral sensing at the blood-brain barrier: new roles for innate immunity at the CNS vasculature.

B P Daniels1, R S Klein.   

Abstract

Neurotropic viral infections are a major source of disease worldwide and represent a growing burden to public health. While the central nervous system (CNS) is normally protected from viral infection by the blood-brain barrier (BBB), many viruses are able to cross the BBB and establish CNS infection through processes that largely remain poorly understood. A growing body of recent research has begun to shed light on the viral and host factors that modulate BBB function, contributing to both protective and pathological disease processes. Central to these studies have been the actions of host cytokines and chemokines, which have increasingly been shown to be key regulators of BBB physiology. This review summarizes recent advances in understanding how BBB function governs both viral pathogenesis and host immune responses during neurotropic viral infections.
© 2015 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Year:  2015        PMID: 25670037     DOI: 10.1002/cpt.75

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Neurotropic Properties of AAV-PHP.B Are Shared among Diverse Inbred Strains of Mice.

Authors:  Yasunori Matsuzaki; Masami Tanaka; Sachiko Hakoda; Tatsuki Masuda; Ryota Miyata; Ayumu Konno; Hirokazu Hirai
Journal:  Mol Ther       Date:  2019-02-28       Impact factor: 11.454

2.  Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages.

Authors:  Li Sun; Xu Wang; Yu Zhou; Run-Hong Zhou; Wen-Zhe Ho; Jie-Liang Li
Journal:  Antiviral Res       Date:  2016-08-03       Impact factor: 5.970

Review 3.  Viral interactions with the blood-brain barrier: old dog, new tricks.

Authors:  Jianghui Hou; Lane A Baker; Lushan Zhou; Robyn S Klein
Journal:  Tissue Barriers       Date:  2016-01-28

4.  Outcomes of RIP Kinase Signaling During Neuroinvasive Viral Infection.

Authors:  Brian P Daniels; Andrew Oberst
Journal:  Curr Top Microbiol Immunol       Date:  2020-04-07       Impact factor: 4.291

5.  RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.

Authors:  Brian P Daniels; Annelise G Snyder; Tayla M Olsen; Susana Orozco; Thomas H Oguin; Stephen W G Tait; Jennifer Martinez; Michael Gale; Yueh-Ming Loo; Andrew Oberst
Journal:  Cell       Date:  2017-03-30       Impact factor: 41.582

6.  Novel approaches to study the Zika virus in the brain.

Authors:  Danielle Beckman; Adele Seelke; John H Morrison; Eliza Bliss-Moreau
Journal:  J Neurosci Res       Date:  2019-07-26       Impact factor: 4.164

7.  Single-cell dissection of the human brain vasculature.

Authors:  Francisco J Garcia; Na Sun; Hyeseung Lee; Brianna Godlewski; Hansruedi Mathys; Kyriaki Galani; Blake Zhou; Xueqiao Jiang; Ayesha P Ng; Julio Mantero; Li-Huei Tsai; David A Bennett; Mustafa Sahin; Manolis Kellis; Myriam Heiman
Journal:  Nature       Date:  2022-02-14       Impact factor: 69.504

8.  Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection.

Authors:  Brian P Daniels; Harsha Jujjavarapu; Douglas M Durrant; Jessica L Williams; Richard R Green; James P White; Helen M Lazear; Michael Gale; Michael S Diamond; Robyn S Klein
Journal:  J Clin Invest       Date:  2017-01-30       Impact factor: 14.808

Review 9.  Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System.

Authors:  Brian P Daniels; Robyn S Klein
Journal:  PLoS Pathog       Date:  2015-09-17       Impact factor: 6.823

10.  Infiltration Pattern of Blood Monocytes into the Central Nervous System during Experimental Herpes Simplex Virus Encephalitis.

Authors:  Rafik Menasria; Coraline Canivet; Jocelyne Piret; Guy Boivin
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.